Jazz Pharmaceuticals plc (NASDAQ:JAZZ) : During the past 4 weeks, traders have been relatively bearish on Jazz Pharmaceuticals plc (NASDAQ:JAZZ), hence the stock is down -8.69% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -2.08% relative to the S&P 500. The 4-week change in the price of the stock is -7.22% and the stock has fallen -0.82% in the past 1 week.
The company shares have dropped -21.79% from its 1 Year high price. On Jul 31, 2015, the shares registered one year high at $194.73 and the one year low was seen on Feb 11, 2016. The 50-Day Moving Average price is $146.79 and the 200 Day Moving Average price is recorded at $136.67.
The stock has recorded a 20-day Moving Average of 2.29% and the 50-Day Moving Average is 5.26%.
Jazz Pharmaceuticals plc (NASDAQ:JAZZ): stock turned positive on Friday. Though the stock opened at $139.66, the bulls momentum made the stock top out at $141 level for the day. The stock recorded a low of $138.14 and closed the trading day at $139.88, in the green by 1.01%. The total traded volume for the day was 899,478. The stock had closed at $138.48 in the previous days trading.
In an insider trading activity,The officer (SVP, US Commercial) of Jazz Pharmaceuticals Plc, Miller Michael Patrick sold 100 shares at $149.64 on June 15, 2016. The Insider selling transaction had a total value worth of $14,964. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.